HCW Biologics prices $1.5M follow-on offering and seeks to reprice existing warrants

HCW Biologics Inc.

Entered securities purchase agreement for follow-on offering of 2,477,292 units at $0.6055 per unit.
Gross proceeds of approximately $1.5 million before fees and expenses.
Common warrants have exercise price of $0.6055 per share, subject to shareholder approval, expire in 5 years.
Agreed to seek shareholder approval to reduce exercise price of existing warrants from $2.41 to $0.6055 per share.
Placement agent Maxim Group LLC will receive a cash fee equal to 6.9% of gross proceeds.

item 1.01item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.